Cargando…

Increased rate of FEV1 decline in HIV patients despite effective treatment with HAART

INTRODUCTION: Previous studies have reported that the rate of FEV1 decline over time is increased in HIV patients but the mechanisms underlying this observation are unclear. Since current HIV treatment with Highly Active Antiretroviral Therapy (HAART) results in very good immune-viral control, we hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samperiz, Gloria, Fanjul, Francisco, Valera, Jose Luis, Lopez, Meritxell, Rios, Ángel, Peñaranda, María, Campins, Antoni, Riera, Melchor, Agusti, Alvar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818778/ https://www.ncbi.nlm.nih.gov/pubmed/31661533 http://dx.doi.org/10.1371/journal.pone.0224510

Ejemplares similares

Interatrial blocks prevalence and risk factors for human immunodeficiency virus-infected persons
por: Fanjul, Francisco, et al.
Publicado: (2019)

Rate of Decline of FEV(1) as a Biomarker of Survival?
por: Papi, Alberto, et al.
Publicado: (2021)

Semen May Harbor HIV Despite Effective HAART: Another Piece in the Puzzle
por: Halfon, Philippe, et al.
Publicado: (2010)

Semen may harbor HIV despite effective HAART: another piece in the puzzle
por: Halfon, Philippe, et al.
Publicado: (2010)

Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD
por: Rosso, Aldana, et al.
Publicado: (2022)

Obstructive sleep apnoea accelerates FEV(1) decline in asthmatic patients
por: Wang, Tsai-Yu, et al.
Publicado: (2017)

Fixed Cut-Off for FEV1/FEV6 and FEV6 in Detection of Obstructive and Restrictive Patterns
por: Aghili, Rokhsareh, et al.
Publicado: (2013)

Systematic review of the evidence relating FEV(1 )decline to giving up smoking
por: Lee, Peter N, et al.
Publicado: (2010)

Risk factors for FEV(1) decline in mild COPD and high-risk populations
por: Chen, Shujing, et al.
Publicado: (2017)

Lower FEV(1) in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV(1), total IgE levels, and TSLP genotypes
por: Masuko, Hironori, et al.
Publicado: (2011)

Reliability of FEV(1)/FEV(6) to Diagnose Airflow Obstruction Compared with FEV(1)/FVC: The PLATINO Longitudinal Study
por: Perez-Padilla, Rogelio, et al.
Publicado: (2013)

Decline in FEV(1) and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency
por: Hiller, Adriana-Maria, et al.
Publicado: (2019)

Evaluating FEV1 decline in diagnosis and management of pulmonary exacerbations in children with cystic fibrosis
por: Bouzek, Drake C., et al.
Publicado: (2022)

Bronchodilator Response of FEV6 and FEV3 as Surrogates of Forced Vital Capacity
por: Mehrparvar, Amir Houshang, et al.
Publicado: (2014)

Genome organization and molecular characterization of the three Formica exsecta viruses—FeV1, FeV2 and FeV4
por: Dhaygude, Kishor, et al.
Publicado: (2019)

Understanding the natural progression in %FEV(1) decline in patients with cystic fibrosis: a longitudinal study
por: Taylor-Robinson, David, et al.
Publicado: (2012)

Polymorphisms of ATF6B Are Potentially Associated With FEV1 Decline by Aspirin Provocation in Asthmatics
por: Park, Tae-Joon, et al.
Publicado: (2014)

Sputum eosinophilia is a determinant of FEV1 decline in occupational asthma: results of an observational study
por: Talini, Donatella, et al.
Publicado: (2015)

Inhaled corticosteroids and FEV(1) decline in chronic obstructive pulmonary disease: a systematic review
por: Whittaker, Hannah R., et al.
Publicado: (2019)

FEV(1) decline in relation to blood eosinophils and neutrophils in a population-based asthma cohort
por: Backman, Helena, et al.
Publicado: (2020)

Routine spirometry in cystic fibrosis patients: impact on pulmonary exacerbation diagnosis and FEV(1) decline
por: de Aquino, Carolina Silva Barboza, et al.
Publicado: (2022)

Cut-off value of FEV(1)/FEV(6) as a surrogate for FEV(1)/FVC for detecting airway obstruction in a Korean population
por: Chung, Kyung Soo, et al.
Publicado: (2016)

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

Systematic review with meta-analysis of the epidemiological evidence relating FEV(1) decline to lung cancer risk
por: Fry, John S, et al.
Publicado: (2012)

Retrospective Analysis of the Relationship between Decline in FEV(1) and Abdominal Circumference in Male Smokers: the Takahata Study
por: Sato, Masamichi, et al.
Publicado: (2012)

Predictors of accelerated FEV(1) decline in adults with airflow limitation—Findings from the Health2006 cohort
por: Baarnes, Camilla Boslev, et al.
Publicado: (2019)

67 CF patients with a declining FEV(1): At risk for acquisition of Burkholderia cepacia complex infection?
por: Willekens, J., et al.
Publicado: (2015)

Rapid FEV(1)/FVC Decline Is Related With Incidence of Obstructive Lung Disease and Mortality in General Population
por: Choi, Kwang Yong, et al.
Publicado: (2022)

A blood and bronchoalveolar lavage protein signature of rapid FEV(1) decline in smoking-associated COPD
por: DiLillo, Katarina M., et al.
Publicado: (2023)

Premature Decline of Serum Total Testosterone in HIV-Infected Men in the HAART-Era
por: Rochira, Vincenzo, et al.
Publicado: (2011)

Utility of FEV(1)/FEV(6) index in patients with multimorbidity hospitalized for decompensation of chronic diseases
por: Komal, Shakeel, et al.
Publicado: (2019)

BMI is associated with FEV(1) decline in chronic obstructive pulmonary disease: a meta-analysis of clinical trials
por: Sun, Yilan, et al.
Publicado: (2019)

Accelerated FEV(1) decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
por: Whittaker, Hannah R., et al.
Publicado: (2021)

Forced Expiratory Volume in 6 s (FEV(6)) and FEV(1)/FEV(6) Values as a Viable Alternative for Forced Vital Capacity (FVC) and FEV(1)/FVC Values During Pregnancy in South East Nigeria: A Preliminary Study
por: Nwagha, U, et al.
Publicado: (2014)

Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
por: Rusconi, S, et al.
Publicado: (2010)

An altered cytotoxic program of CD8(+) T-cells in HIV-infected patients despite HAART-induced viral suppression
por: Perdomo-Celis, Federico, et al.
Publicado: (2019)

Effects of simvastatin in chronic obstructive pulmonary disease: Results of a pilot, randomized, placebo-controlled clinical trial
por: Balaguer, Catalina, et al.
Publicado: (2016)

Nephrotoxicity of HAART
por: Kalyesubula, Robert, et al.
Publicado: (2011)

Genetic variation in TIMP1 but not MMPs predict excess FEV(1 )decline in two general population-based cohorts
por: van Diemen, CC, et al.
Publicado: (2011)

COPD-associated miR-145-5p is downregulated in early-decline FEV(1) trajectories in childhood asthma
por: Tiwari, Anshul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5hn0l0pvjavae446hbn21d2u3o